Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study

Impact of Levosimendan and Its Metabolites on Platelet Activation Mechanisms in Patients during Antiplatelet Therapy—Pilot Study

Levosimendan is used for the short-term treatment of severe heart failure or other cardiac conditions. The area of existing clinical applications for levosimendan has increased significantly. This study aimed to assess whether levosimendan and its metabolites impact the mechanisms related to platele...

Full description

Bibliographic Details
Main Authors: Joanna Sikora, Krzysztof Pstrągowski, Aleksandra Karczmarska-Wódzka, Patrycja Wszelaki, Katarzyna Buszko, Zbigniew Włodarczyk
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
platelets
ADP
levosimendan
aggregation
antiplatelet therapy
Online Access:https://www.mdpi.com/1422-0067/25/3/1824

Internet

https://www.mdpi.com/1422-0067/25/3/1824

Similar Items